Cionic, Inc.
7
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
28.6%
2 terminated/withdrawn out of 7 trials
50.0%
-36.5% vs industry average
0%
0 trials in Phase 3/4
100%
2 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Gait Metric Validation of the Cionic Neural Sleeve
Role: lead
Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease
Role: lead
Tracking Self-Reported Functional Needs and Quality of Life
Role: lead
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Role: lead
A 12-Week Home-Based Electrical Stimulation Program for Strength in Adults With Knee Osteoarthritis
Role: lead
Pediatric Neural Sleeve Validation
Role: collaborator
Augmenting Gait in a Population Exhibiting Foot Drop With Adaptive Functional Electrical Stimulation
Role: lead
All 7 trials loaded